Clinical Trial Update: Molecular Effects of Topical Calcipotriene on Morphea [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating molecular effects of topical calcipotriene on morphea (localized scleroderma) has been terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Scleroderma
• Morphea

Drugs mentioned

• Calcipotriene (calcipotriene)

Snippet

Sponsor: Northwestern University | Conditions: Morphea, Localized Scleroderma | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-09-13